Brain microbleeds: more evidence, but still a clinical dilemma
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
PURPOSE OF REVIEW: Brain microbleeds (BMBs) are a radiological construct that is meant to represent a specific underlying microscopic pathology: perivascular collections of hemosiderin deposits. BMBs may represent two different types of underlying vasculopathies: hypertensive vasculopathy and cerebral amyloid angiopathy. This brief review highlights some recent works discussing their nature, and both their diagnostic and prognostic values. RECENT FINDINGS: The improvement of detection techniques has modified our perception of BMBs prevalence, which can reach 35% among healthy people compared with 5% when conventional techniques are used. Our knowledge on BMBs is evolving very quickly. The careful study of their anatomical distribution sheds light on their histological significance: deep BMBs may represent hypertensive vasculopathies and lobar ones cerebral amyloid angiopathy. SUMMARY: Despite an explosion of publications on BMBs, their diagnostic and prognostic values have only received indirect support and remain to be explored. To date, BMBs should not contraindicate antithrombotic treatment in settings wherein benefits have clearly been demonstrated in clinical trials and meta-analyses. One intriguing field is Alzheimer's disease, in which BMBs may be a missing link between two important theories on the neuropathogenesis of Alzheimer's disease: the amyloid cascade hypothesis and the vascular hypothesis.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cerebral microbleeds: a guide to detection and interpretation
Greenberg, S. M., Vernooij, M. W., Cordonnier, C., Viswanathan, A., Al-Shahi Salman, R., Warach, S., Launer, L. J., Van Buchem, M. A., & Breteler, M. M. (2009) · The Lancet Neurology · doi:10.1016/s1474-4422(09)70013-4 · Cited by 1,798
Self-citationClinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria
Knudsen, K. A., Rosand, J., Karluk, D., & Greenberg, S. M. (2001) · Neurology · doi:10.1212/wnl.56.4.537 · Cited by 1,015
Cordonnier, C., Al-Shahi Salman, R., & Wardlaw, J. (2007) · Brain · doi:10.1093/brain/awl387 · Cited by 703
Self-citationGoos, J. D. C., Kester, M. I., Barkhof, F., Klein, M., Blankenstein, M. A., Scheltens, P., & van der Flier, W. M. (2009) · Stroke · doi:10.1161/strokeaha.109.558197 · Cited by 213
Serial Susceptibility Weighted MRI Measures Brain Iron and Microbleeds in Dementia
Kirsch, W., McAuley, G., Holshouser, B., Petersen, F., Ayaz, M., Vinters, H. V., Dickson, C., Haacke, E. M., Britt III, W., Larsen, J., et al. (2009) · Journal of Alzheimer's Disease · doi:10.3233/jad-2009-1073 · Cited by 139
Staekenborg, S. S., Koedam, E. L. G. E., Henneman, W. J. P., Stokman, P., Barkhof, F., Scheltens, P., & van der Flier, W. M. (2009) · Stroke · doi:10.1161/strokeaha.108.531343 · Cited by 139
Cited by
Neurovascular pathways to neurodegeneration in Alzheimer’s disease and other disorders
Zlokovic, B. V. (2011) · Nature Reviews Neuroscience · doi:10.1038/nrn3114 · Cited by 2,969
Neurovascular Dysfunction and Faulty Amyloid -Peptide Clearance in Alzheimer Disease
Sagare, A. P., Bell, R. D., & Zlokovic, B. V. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a011452 · Cited by 251
Cerebral Microbleeds as a Biomarker in Alzheimer’S Disease? A Review in The Field
Shams, S., & Wahlund, L.-O. (2016) · Biomarkers in Medicine · doi:10.2217/bmm.15.101 · Cited by 32
Metadata
- Authors
- Cordonnier, C.
- Venue
- Current Opinion in Neurology
- Published
- 2011-02
- Volume
- 24
- Issue
- 1
- Pages
- 69-74
- ISSN
- 1350-7540 (ISSN-L)
- OpenAlex
- W2031415570
- Cited by
- 38
- References
- 6
- FWCI
- 1.74
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Brain microbleeds: more evidence, but still a clinical dilemma. https://app.cochat.ai/papers/10.1097/wco.0b013e328341f8c0
- The paper
- Cordonnier, C. (2011). Brain microbleeds: more evidence, but still a clinical dilemma. Current Opinion in Neurology. https://doi.org/10.1097/wco.0b013e328341f8c0
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.